NDC 62484-1020-04 - MERCAPTOPURINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62484-1020
- Requested NDC
- 62484-1020-04
- Package NDCs from labels
- 62484-1020-3, 62484-1020-4, 62484-1020-04
- Manufacturer
- Nova Laboratories, Ltd | Rare Disease Therapeutics, Inc.
- Effective date
- 2026-07-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MERCAPTOPURINE - Nova Laboratories, Ltd | Rare Disease Therapeutics, Inc. | Nova Laboratories, Ltd | Rare Disease Therapeutics, Inc. | 2026-07-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62484-1020-3 | MERCAPTOPURINE | 100 mL in 1 BOTTLE | SUSPENSION | 100 | 5 | |
| 62484-1020-4 | MERCAPTOPURINE | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62484-1020-3 | ML - Milliliter | 62484-1020 | dd0f8efa-9c8b-49eb-9b93-92955dcc4e5c | 1 | 2026-01-08 |
| 62484-1020-4 | ML - Milliliter | 62484-1020 | 86967a7d-8a03-48ec-8537-519afe094ded | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MERCAPTOPURINE | MERCAPTOPURINE | Hikma Pharmaceuticals USA Inc. | 0a366cf3-91f0-4aa4-8f34-a7a27cad8f15 | 2026-07-22 | Warnings, Adverse reactions | 1536484 E7WED276I5 |
| PURIXAN | PURIXAN | Nova Laboratories, Ltd | 9fd27952-7787-47d9-b6cf-7af2dc38217b | 2026-07-20 | Warnings, Adverse reactions | NDA205919 1536484 E7WED276I5 |
| MERCAPTOPURINE | MERCAPTOPURINE | Nova Laboratories, Ltd | 9c6fc66b-522f-499d-961a-cde6ca0ec2e5 | 2026-07-20 | Warnings, Adverse reactions | NDA205919 62484-1020-3 62484-1020-4 62484-1020 62484102004 1536484 e8f4fd0d-a6b3-4c9c-bf62-78bdb81c703d 9c6fc66b-522f-499d-961a-cde6ca0ec2e5 E7WED276I5 |
| Mercaptopurine | MERCAPTOPURINE | Golden State Medical Supply, Inc. | 4bae5ffb-a535-3fa0-e063-6294a90aa90a | 2026-02-25 | Warnings, Adverse reactions | E7WED276I5 |
| Mercaptopurine | MERCAPTOPURINE | Florida Pharmaceutical Products, LLC | e7309808-5ae8-4a55-90e3-3992ace0da62 | 2026-01-30 | Warnings, Adverse reactions | E7WED276I5 |
| MERCAPTOPURINE | MERCAPTOPURINE | Hikma Pharmaceuticals USA Inc. | 25b39be7-fe1e-efe6-e063-6294a90a6e8d | 2024-11-22 | Warnings, Adverse reactions | 1536484 E7WED276I5 |
| Mercaptopurine | MERCAPTOPURINE | Hikma Pharmaceuticals USA Inc. | c3b5b8b0-bc5c-4ce9-bbdc-febba60c2658 | 2024-10-01 | Warnings, Adverse reactions | E7WED276I5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.